glycosaminoglycans

Preferred Label : glycosaminoglycans;

MeSH definition : Heteropolysaccharides which contain an N-acetylated hexosamine in a characteristic repeating disaccharide unit. The repeating structure of each disaccharide involves alternate 1,4- and 1,3-linkages consisting of either N-acetylglucosamine or N-acetylgalactosamine.; Heteropolysaccharides which contain an N-acetylated hexosamine in a characteristic repeating disaccharide unit. The repeating structure of each disaccharide involves alternate 1,4- and 1,3-linkages consisting of either N-acetylglucosamine (see ACETYLGLUCOSAMINE) or N-acetylgalactosamine (see ACETYLGALACTOSAMINE).;

MeSH synonym : mucopolysaccharides; Glycosaminoglycan;

CISMeF acronym : GAG;

MeSH annotation : polysaccharides; note X ref;

Wikipedia link : https://en.wikipedia.org/wiki/Glycosaminoglycan;

Is substance : O;

Détails

Origin ID

D006025;

UMLS CUI

C0017973;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- GAG Gene [NCIt concept]
- Glycosaminoglycans measurement (procedure) [SNOMED CT concept]
- Mycteroperca microlepis (organism) [SNOMED CT concept]
- mucopolysaccharides [IUPAC Term]
Currated CISMeF NLP mapping
- Glycosaminoglycan [NCIt concept]
- Glycosaminoglycan [FMA entity]
- Glycosaminoglycans [LOINC component]
- Mucopolysaccharide (substance) [SNOMED CT concept]
- glycosaminoglycan [IUPAC Term]
- mucopolysaccharide, nos [SNOMED Notion]
Indexing information
- GAG-BP protein, streptococcus pyogenes [MeSH Supplementary Concept]
- ZBP1 protein, human [MeSH Supplementary Concept]
- Zbp1 protein, mouse [MeSH Supplementary Concept]
- glucidamine [MeSH Supplementary Concept]
- membrane-associated factor, rat [MeSH Supplementary Concept]
Record concept(s)
- glycosaminoglycans [MeSH concept]
Related MeSH Supplementary Concept(s)
- A73025 [MeSH Supplementary Concept]
- Arteparon [MeSH Supplementary Concept]
- COS 8 preparation [MeSH Supplementary Concept]
- DAK 16 [MeSH Supplementary Concept]
- N-acetylheparosan [MeSH Supplementary Concept]
- OTD70DERM [MeSH Supplementary Concept]
- OTR4120 [MeSH Supplementary Concept]
- acharan sulfate [MeSH Supplementary Concept]
- biostite [MeSH Supplementary Concept]
- collagen-glycosaminoglycan copolymer [MeSH Supplementary Concept]
- depolymerized holothurian glucosaminoglycan [MeSH Supplementary Concept]
- enterosan [MeSH Supplementary Concept]
- foltene [MeSH Supplementary Concept]
- fucomucins [MeSH Supplementary Concept]
- galactosamine glucuronoglycan sulfate [MeSH Supplementary Concept]
- glucosaminoglycans [MeSH Supplementary Concept]
- glucuronyl glucosamine glycan sulfate [MeSH Supplementary Concept]
- glycagen [MeSH Supplementary Concept]
- glycosaminoglucuronates [MeSH Supplementary Concept]
- glycosaminoglycan glucuronyltransferase I [MeSH Supplementary Concept]
- hemovasal [MeSH Supplementary Concept]
- hexosaminoglycans [MeSH Supplementary Concept]
- hexuronyl hexosaminoglycan sulfate [MeSH Supplementary Concept]
- illexin [MeSH Supplementary Concept]
- imedeen [MeSH Supplementary Concept]
- isopropyl 2-deoxy-2-sulfoaminoglucopyranosyl-(1-4)-2-O-sulfoidouronosyl-(1-4)-2-deoxy-2-acetylamino-6-O-sulfoglucopyranosyl-(1-4)-idouronosyl-(1-4)-2-deoxy-2-sulfoaminoglucopyransoyl-(1-4)-2-sulfoidouronoside [MeSH Supplementary Concept]
- mesoglycan [MeSH Supplementary Concept]
- mitrin [MeSH Supplementary Concept]
- mobilisin [MeSH Supplementary Concept]
- mucoid exopolysaccharide (P aeruginosa) [MeSH Supplementary Concept]
- mucopolysaccharide polysulfate [MeSH Supplementary Concept]
- naoxinshu [MeSH Supplementary Concept]
- sanaven [MeSH Supplementary Concept]
- sporotrichin [MeSH Supplementary Concept]
- technetium 99m P1827DS [MeSH Supplementary Concept]
See also inter- (CISMeF)
- mucopolysacchariduria [CISMeF Querying Strategy]
Semantic type(s)
- Biologically Active Substance [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Glycosaminoglycan [FMA entity]
- Glycosaminoglycan [NCIt concept]
- Glycosaminoglycans [LOINC component]
- Mucopolysaccharide (substance) [SNOMED CT concept]
- glycosaminoglycan [IUPAC Term]
- mucopolysaccharide, nos [SNOMED Notion]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients